Electromed Inc
AMEX:ELMD
Net Margin
Electromed Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
E
|
Electromed Inc
AMEX:ELMD
|
191.6m USD |
11%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.1B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
134.9B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.5B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
256.5B CNY |
33%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
31.3B USD |
25%
|
Electromed Inc
Glance View
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Electromed Inc's most recent financial statements, the company has Net Margin of 11.3%.
You don't have any saved screeners yet